Dr. Sachi Horibata is a Tenure-Track Assistant Professor of Precision Health Program at the College of Human Medicine at Michigan State University (MSU). Her laboratory works on understanding the development and evolution of cancer drug resistance and the identification of therapeutic targets for personalized medicine.
Prior to MSU, Dr. Horibata received her postdoctoral training at National Cancer Institute at the National Institutes of Health in the laboratory of Dr. Michael Gottesman where she characterized heterogeneity in acute myeloid leukemia patients. Dr. Horibata received her Ph.D. in Pharmacology from Cornell University where she investigated how posttranslational modification promoted breast cancer metastasis and resistance to hormone therapy.
Dr. Sachi Horibata is a Tenure-Track Assistant Professor of Precision Health Program at the College of Human Medicine at Michigan State University (MSU). Her laboratory works on understanding the development and evolution of cancer drug resistance and the identification of therapeutic targets for personalized medicine.
Prior to MSU, Dr. Horibata received her postdoctoral training at National Cancer Institute at the National Institutes of Health in the laboratory of Dr. Michael Gottesman where she characterized heterogeneity in acute myeloid leukemia patients. Dr. Horibata received her Ph.D. in Pharmacology from Cornell University where she investigated how posttranslational modification promoted breast cancer metastasis and resistance to hormone therapy.
Research Interests:
Sachi Horibata
Achievements:
Cornell University
Horibata Lab